重新审视ISCHEMIA试验:厘清冠状动脉旁路移植术的获益与对一项里程碑试验的误读
本文详细分析ISCHEMIA试验,旨在厘清冠状动脉旁路移植术(CABG)的获益并纠正对该里程碑试验的误读。作者认为ISCHEMIA中期结果与既往证据一致,即CABG降低晚期冠状动脉疾病的长期心肌梗死和死亡风险,不应据此下调指南中对CABG不可否认获益的推荐。
要点
- ISCHEMIA试验中期结果与既往证据一致:CABG降低晚期冠心病长期心肌梗死和死亡风险。
- 侵入性策略心血管死亡率显著更低而非心血管死亡率更高,作者按里程碑证据进行解释。
- 作者认为不应利用ISCHEMIA试验结果下调近期指南中对CABG不可否认获益的推荐。
核心结论
- ISCHEMIA试验结果与既往证据一致,不应被用于下调近期指南中对CABG不可否认获益的推荐。
研究设计与样本
- 本文为对ISCHEMIA试验的详细分析,旨在厘清CABG的获益并纠正对该里程碑试验的误读。
主要发现
- ISCHEMIA试验中期结果与既往证据一致,即CABG降低晚期冠状动脉疾病的长期心肌梗死和死亡风险。
- 侵入性策略心血管死亡率显著更低而非心血管死亡率更高,作者按里程碑证据对此进行解释。
临床怎么用
- 作者认为不应利用ISCHEMIA试验结果下调近期指南中对CABG不可否认获益的推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The ISCHEMIA trial is a landmark study that has been the subject of heated debate within the cardiovascular community. In this analysis of the ISCHEMIA trial, we aim to set the record straight on the benefits of coronary artery bypass grafting (CABG) and the misinterpretation of this landmark trial. We sought to clarify and reorient this misinterpretation. METHODS: We herein analyse the ISCHEMIA trial in detail and describe how its misinterpretation has led to an erroneous guideline recommendation downgrading for prognosis-altering surgical therapy in these at-risk patients. RESULTS: The interim ISCHEMIA trial findings align with previous evidence where CABG reduces the long-term risks of myocardial infarction and mortality in advanced coronary artery disease. The trial outcomes of a significantly lower rate of cardiovascular mortality and a higher rate of non-cardiovascular mortality with the invasive strategy are explained according to landmark evidence. CONCLUSIONS: The ISCHEMIA trial findings are aligned with previous evidence and should not be used to downgrade recommendations in recent guidelines for the indisputable benefits of CABG.
引用
- Gomes WJ, Marin-Cuartas M, Bakaeen F, et al. The ISCHEMIA trial revisited: setting the record straight on the benefits of coronary bypass surgery and the misinterpretation of a landmark trial. Eur J Cardiothorac Surg. 2023. PMID: 37889258. doi:10.1093/ejcts/ezad361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。